AGP Picks
View all

The Boston Examiner
Provided by AGP

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on October 7, 2026

V2 Communications Launches Public Sector Practice to Help Technology Companies Build Trust and Visibility with Government Buyers
Oct. 7, 2026

V2 Communications Launches Public Sector Practice to Help Technology Companies Build Trust and Visibility with Government Buyers

Indeterminate GlobeNewswire
IDC empowers Technology Leaders with IDC Quanta, an AI platform that accelerates enterprise decisions and future-proofs investments for the AI era
Oct. 7, 2026

IDC empowers Technology Leaders with IDC Quanta, an AI platform that accelerates enterprise decisions and future-proofs investments for the AI era

Indeterminate GlobeNewswire
Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide
Oct. 7, 2026

Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial Results Demonstrating Favorable Safety and Tolerability Profile for Ruvonoflast in Combination with Semaglutide

Indeterminate GlobeNewswire
Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease
Oct. 7, 2026

Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease

Indeterminate GlobeNewswire
Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
Oct. 7, 2026

Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum

Indeterminate GlobeNewswire
New MIT Sloan research finds a “Bamboo Ceiling” for ethnic Chinese men in the UK
Oct. 7, 2026

New MIT Sloan research finds a “Bamboo Ceiling” for ethnic Chinese men in the UK

Indeterminate GlobeNewswire
Crane NXT Appoints Jeong H. Kim to Board of Directors
Oct. 7, 2026

Crane NXT Appoints Jeong H. Kim to Board of Directors

Indeterminate GlobeNewswire
Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026
Oct. 7, 2026

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Indeterminate GlobeNewswire
Atavistik Bio to Present at the Cure HHT 16th International Scientific Conference
Oct. 7, 2026

Atavistik Bio to Present at the Cure HHT 16th International Scientific Conference

Indeterminate GlobeNewswire
Always Connected Selects iBASIS to Launch New Travel eSIM Services
Oct. 7, 2026

Always Connected Selects iBASIS to Launch New Travel eSIM Services

Indeterminate GlobeNewswire
Sereact, Zalando and CEVA Logistics start AI-powered, automated returns handling in Germany and Poland
Oct. 7, 2026

Sereact, Zalando and CEVA Logistics start AI-powered, automated returns handling in Germany and Poland

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.